Literature DB >> 6468439

The failure of parenteral copper therapy in Menkes Kinky Hair syndrome.

A D Garnica.   

Abstract

In the untreated infant with Menkes Kinky Hair Syndrome, copper concentrations in brain and liver are deficient, while excessive copper accumulates in other tissues. The observed serum ceruloplasmin response after parenteral copper administration is suggestive of an impairment in the incorporation of copper into this metalloprotein. These findings, together with increased urinary copper excretion and the absence of clinical improvement, are compatible with a generalized defect in copper metabolism, transport or storage. The excessive accumulation of copper in many tissues illustrates the potential danger of parenteral copper therapy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6468439     DOI: 10.1007/bf00445587

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  32 in total

1.  Evidence for ceruloplasmin as a copper transport protein.

Authors:  H S Hsieh; E Frieden
Journal:  Biochem Biophys Res Commun       Date:  1975-12-15       Impact factor: 3.575

Review 2.  Iron and copper metabolism during development.

Authors:  M C Linder; H N Munro
Journal:  Enzyme       Date:  1973

3.  Biological applications of the carbon rod atomizer in atomic absorption spectroscopy. 2. Determination of copper in small samples of tissue.

Authors:  B J Stevens
Journal:  Clin Chem       Date:  1972-11       Impact factor: 8.327

4.  The association of the copper derived from ceruloplasmin with cytocuprein.

Authors:  N Marceau; N Aspin
Journal:  Biochim Biophys Acta       Date:  1973-12-06

5.  Simultaneous direct estimation by atomic absorption spectrophotometry of copper and zinc in serum, urine, and cerebrospinal fluid.

Authors:  S Meret; R I Henkin
Journal:  Clin Chem       Date:  1971-05       Impact factor: 8.327

6.  Letter: Parenteral copper in Menkes' kinky-hair syndrome.

Authors:  A D Garnica; S R Fletcher
Journal:  Lancet       Date:  1975-10-04       Impact factor: 79.321

7.  Extra-hepatic storage of copper: a male foetus suspected of Menkes' disease.

Authors:  K Keydorn; E Damsgaard; N Horn; M Mikkelsen; I Tygstrup; S Vestemark; J Weber
Journal:  Humangenetik       Date:  1975-09-10

8.  Copper metabolism in mottled mouse mutants: copper concentrations in tissues during development.

Authors:  J Camakaris; J R Mann; D M Danks
Journal:  Biochem J       Date:  1979-06-15       Impact factor: 3.857

9.  Altered copper metabolism in cultured cells from human Menkes' syndrome and mottled mouse mutants.

Authors:  J Camakaris; D M Danks; L Ackland; E Cartwright; P Borger; R G Cotton
Journal:  Biochem Genet       Date:  1980-02       Impact factor: 1.890

10.  Increased copper metallothionein in Menkes cultured skin fibroblasts.

Authors:  G U Labadie; K Hirschhorn; S Katz; N G Beratis
Journal:  Pediatr Res       Date:  1981-03       Impact factor: 3.756

View more
  5 in total

1.  Copper histidinate therapy in Menkes' disease: prevention of progressive neurodegeneration.

Authors:  G Sherwood; B Sarkar; A S Kortsak
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Golgi study on macular mutant mouse after copper therapy.

Authors:  H Kawasaki; T Yamano; S Iwane; M Shimada
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

3.  Sibling cases of a degenerative neurological disease associated with hypocupraemia and hypobetalipoproteinaemia.

Authors:  Y Iwakawa; M Shimohira; J Kohyama; H Kodama
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

4.  Menkes' disease: long-term treatment with copper and D-penicillamine.

Authors:  D Nadal; K Baerlocher
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

5.  Clinical and biochemical consequences of copper-histidine therapy in Menkes disease.

Authors:  J Kreuder; A Otten; H Fuder; Z Tümer; T Tønnesen; N Horn; D Dralle
Journal:  Eur J Pediatr       Date:  1993-10       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.